chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient seen in the ED on 12/13/22 for 2-3 days of headache, weakness, cough, fever, and shortness of breath with exertion.  She reported testing COVID positive at home, and also tested positive for COVID by PCR in the ED. In the ED, patient found to be hypoxic at 86% with ambulation. She was admitted 12/13/22 - 12/15/22. Patient was on O2 but was weaned off completely. Discharge diagnosis included acute hypoxic respiratory failure due to COVID-19, among other diagnoses. She has been vaccinated for COVID-19.
had every side effect like having the virus.; difficult in breathing; runny nose; didn't want to eat; cough; headache; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (had every side effect like having the virus.), DYSPNOEA (difficult in breathing), RHINORRHOEA (runny nose), DECREASED APPETITE (didn't want to eat) and COUGH (cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient had virus for 3 months).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced ADVERSE REACTION (had every side effect like having the virus.), DYSPNOEA (difficult in breathing), RHINORRHOEA (runny nose), DECREASED APPETITE (didn't want to eat), COUGH (cough), HEADACHE (headache), PYREXIA (fever) and FATIGUE (fatigue). At the time of the report, ADVERSE REACTION (had every side effect like having the virus.), DYSPNOEA (difficult in breathing), RHINORRHOEA (runny nose), DECREASED APPETITE (didn't want to eat), COUGH (cough), HEADACHE (headache), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.    This case was linked to MOD-2021-118963 (Patient Link).
After the 4th day of the shot I wasn't feeling good, I was always dizzy, Short of Breath, Exhausted where it was hard to even get out of bed.  Even trying to clean my house made it worse where I could not catch my breath.   I could not drive do to my condition my Husband had to take off of work to take me to my Doctors Office
Pt developed cellulitis at site of injection.  Md diagnosed and prescribed cephalexin.
She has little reaction to it; today she starts to have a fever and faster heartbeat; She has little reaction to it; today she starts to have a fever and faster heartbeat; numb legs (and sometimes hands); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 26 year-old female patient received bnt162b2 (BNT162B2), administration date 27Apr2021 (Lot number: EW0169) at the age of 26 years as dose 2.,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose , Lot : EW0162), administration date: Apr2021, when the patient was 26 years old, for COVID-19 Immunization.  The following information was reported: HEART RATE INCREASED (non-serious), PYREXIA (non-serious) all with onset 28Apr2021 16:00, outcome "recovered" (28Apr2021 22:00) and all described as "She has little reaction to it; today she starts to have a fever and faster heartbeat"; HYPOAESTHESIA (non-serious) with onset 28Apr2021 16:00, outcome "recovered" (28Apr2021 22:00), described as "numb legs (and sometimes hands)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of heart rate increased, pyrexia, hypoaesthesia.  Additional information: Any other Products that were taken together with those indicated above: No. She had the Numb legs (hands sometimes) for about 2 to 3 hours. Reporter stated question was his girlfriend got the second shot (Unspecified Vaccine) last night and she has little reaction to it. So, no problem but today she started to have a fever and faster heartbeat. Reporter wanted to know was she need to go to the emergency room. Admission of hospital due to event: No. Treatment: Yes Ibuprofen.  Follow-up attempts are completed. No further information is expected.
Whole body Muscle pain Severe Flank pain Headache Nausea Low grade Fever  Stiff neck
bulls eye lesion that is still present several weeks later and comes and goes with pain and swelling, muscle twitches
pt recv vax 8MAR96 & 7AUG96 & revealed a lack of seroconversion;
Pt. received vaccines at 8:39 in clinic. Developed a fever of 101. PO intake decreased by 2000 the night of receiving vaccines. Mom gave TYLENOL. T. max 104.5 w/last dose of TYLENOL given at midnight. Pt. was taken to the ER. Pt. also had 3 loose stools; 4 episodes of emesis.
Felt horrible; In and out of sleep; Rash on her back side; Fever; Chillls; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt horrible), SOMNOLENCE (In and out of sleep), RASH (Rash on her back side), PYREXIA (Fever) and CHILLS (Chillls) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced ILLNESS (Felt horrible), SOMNOLENCE (In and out of sleep), RASH (Rash on her back side), PYREXIA (Fever) and CHILLS (Chillls). At the time of the report, ILLNESS (Felt horrible), SOMNOLENCE (In and out of sleep), RASH (Rash on her back side), PYREXIA (Fever) and CHILLS (Chillls) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No corrective treatment was provided.
This case was reported by a healthcare professional and described the occurrence of swelling of legs in a 4-month-old female subject who was vaccinated with PEDIARIX (GlaxoSmithKlein).  Previous and/or concurrent vaccination included PEDIARIX (GlaxoSmithKlein); unknown given on an unspecified date.  On 27 November 2007, the subject received 3rd dose of PEDIARIX (.5 ml, unknown,left thigh).  On 27 November 2007, less than one day after vaccination with PEDIARIX, the subject developed swelling of legs, pain, and fever that lasted a few days and resolved.  The reporting healthcare professional stated the subject was vaccinated at another site and did not have the information to provide.  The subject did not have these reactions with the two previous PEDIARIX vaccinations.  Teh healthcare professional reported that this was the 3rd immunization in the PEDIARIX series and that would be considered too early at the age of 4-months to have received three vaccinations (inappropriate schedule of vaccine administered).  On 1 December 2007, the events of swelling of legs, pain and fever had resolved.  The healthcare professional considered the events of swelling of legs, pain, and fever as probably related to vaccination with PEDIARIX.
Per mom pt has had no reactions DTaP #1, but increasing reactions with #2, #3. She noted usual reaction until 8/1/03 a.m. when upper right arm quite indurated and red. That's the case at today's exam. No other findings.
Numbness started in scrotum and moved down legs and upper chest with severe nerve pain. Slowly becoming unable to walk with out a walker. Ten day?s ago moved down his arms  and nerve pain in his hands is so severe he can?t hold a glass or a utensil to feed himself. What ever this is is slowly getting worse but started after the first dose of vaccine, has not got the second dose.
patient complained of stabbing pain in left temple at time of departure.  BP 176/81 82 16.  BP taken two times   again, 5 minutes apart continue to be 185/ 87.  Encouraged to call Primary regarding HTN.  No further vaccine   reactions noted.
Information has been received from a registered nurse concerning a 9 month old patient who on 16-MAR-2011, was vaccinated with a dose of VAQTA, 0.5 mL, IM. The patent who was intended to receive hepatitis B virus vaccine, inadvertently was administered VAQTA. No adverse symptoms reported. At the time of the report the outcome of the patient was unknown. Additional information has been requested.
Fever - 3-4 days, 102.7 degrees when measured a couple of times Chills - 2-3 days Pounding headache - 2-3 days Pounding heartrate Fatigue - 5 days
fever of 100.6-102.5 for 2 days, chills/shivering, weak, body aches, headache.  Tylenol and stayed hydrated
This spontaneous report as received from a registered nurse refers to herself, a female of unknown age No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 18-MAY-2017, the patient was vaccinated with third dose of GARDASIL 9 (lot number and expiration not reported) for prophylaxis. On 18-MAY-2017, the patient experienced pain at the injection site. No further information was provided. The outcome of injection site pain is unknown. Additional information has been requested.
Vaccine administered on 2/15/12 to (L) arm. Redness to site, warm to touch, tenderness with palpation.
It was reported that a 42 year old female patient received a Typhim VI vaccination in January 2000 (exact date not specified) and subsequently developed swollen lymph nodes in the groin area which lasted several weeks. Patient also developed an injection site reaction characterized by swelling and soreness, which lasted four days. Reportedly the patient recovered from this experience.
chills; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and FATIGUE (felt tired) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical history was reported.     In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and FATIGUE (felt tired). At the time of the report, CHILLS (chills) and FATIGUE (felt tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient mentioned that her husband also has the antibodies and took first dose of vaccine. No treatment information was provided. No concomitant product was reported.
This spontaneous report as received from a physician refers to unspecified number of patients of unknown demographics. On an unknown date, an unspecified number of patients may have received ROTATEQ 0.5 milliliters suspension, orally (Lot# J008362, expiry date: not provided). The reporter reported that ROTATEQ were exposed to a lowest temperature of 32F (Fahrenheit) for a total of 1 hour over "four different occasions" and the improperly stored ROTATEQ were administered orally to an unspecified amount of patients. No adverse effect was reported. There was no product quality complaint involved. Outcome of medication error was unknown. The case is linked to 1405USA004024, 1405USA011937, 1405USA011938, 1405USA009508, 1405USA011939, 1406USA009955, 1406USA009970, 1406USA009971, 1406USA009972, 1406USA009974, 1406USA009977, and 1406USA009978 (same reporter link). Additional information has been requested.
mixed normal saline with Moderna COVID19 vial; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT PREPARATION ISSUE (mixed normal saline with Moderna COVID19 vial) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 ml. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, the patient experienced PRODUCT PREPARATION ISSUE (mixed normal saline with Moderna COVID19 vial). On 17-Aug-2021, PRODUCT PREPARATION ISSUE (mixed normal saline with Moderna COVID19 vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant drugs were reported. No treatment was reported.  It was reported that when administering the Moderna COVID-19 vaccine, the medical assistant mixed normal saline with the Moderna vaccine vial. She mixed 2 mLs of normal saline into the vial of the vaccine and administered 0.5 mL to each patient. The patient was not experiencing any symptoms and was monitored for 15 minutes. This was the second dose for the patient.
A non-serious spontaneous report of "they inadvertently administered H1N1 to a person greater than 49 years of age", was received from a registered nurse/health professional concerning an adult of unknown gender. Neither relevant medical history nor concomitant medications were reported. On 29-Jan-2010, the patient received H1N1, Intranasal, for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
First injection I had no adverse effects. 10 days after my second injection, the lymph node under my arm -- the one that received the injection -- flared up again (it had become inflamed the first three days after the second injection but quickly got better). It's been about five days, and it seems to have gone down / that pain has largely subsided. Additionally, both upper arms feel "heavy" and my hands are weak. It's not as easy to make a fist. It's hard to describe, but my arms just feel a little weaker.
pt recv vax 1SEP95 & 3 months p/2nd dose of vax on 8DEC95 pt titer was again reported as negative w/a value less than 0.8;no further details were provided
Pt was fully immunized and pretty much on schedule but was still diagnosed with pertussis per PCR on 3/13/2009. Immunizations dates were 11/16/2005, 01/25/2006, 06/28/2006, 02/22/2007
Starting the day after my first shot, I have experienced being lightheaded throughout the day and evening.
Patient was admitted to Hospital on 12/23/2021.  The only symptom charted in system is high fever. Patient tested at same facility on 12/31/2021 for covid: positive. No underlying health conditions listed.
swelling in the throat; face flushed; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of PHARYNGEAL SWELLING (swelling in the throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history reported).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PHARYNGEAL SWELLING (swelling in the throat) (seriousness criterion intervention required). On 03-Mar-2021, PHARYNGEAL SWELLING (swelling in the throat) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medications were reported. Treatment in the ER included a corticosteroid shot. The patient was told by ER doctor that the Moderna COVID-19 vaccine may be negated.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
had the vaccine, still breakout/Suspected vaccination failure; dime sized breakout; itch; pain; Scratch; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had the vaccine, still breakout/Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: dime sized breakout), pruritus (Verbatim: itch), pain (Verbatim: pain) and scratch (Verbatim: Scratch). The outcome of the vaccination failure was unknown and the outcome of the shingles, pruritus, pain and scratch were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, pruritus, pain and scratch to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure, shingles, pruritus, pain and scratch to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient had the shingles vaccine but he/she still got a dime-sized breakout on occasions.  The reporter stated that an itch you scratch and a pain you could not stop. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
This spontaneous report as received from a registered nurse (R.N.) refers to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates (before expiration dates), the patients were vaccinated with improperly stored VAQTA (lot # K008254, expiration date 12=NOV-2015; lot # L004439, expiration date 15-FEB-2015; lot # K015827, expiration date 11-MAR-2016; lot # L013380, expiration date 04-NOV-2017; lot # L023232, expiration date 25-FEB-2017; lot # L022259, expiration date 06-APR-2017; lot # L030442, expiration date 19-DEC-2016; lot # L042631, expiration date 16-FEB-2016; route and dose were not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Present on 8/11 following 4-5 days of myalgias, fevers and fatigue. Received only 1 dose of cvocid vaccine. Admitted and started on antibiotics. COVID +. Given decadron and 5 day course of remdesivir. His stay was complicated by AKI and CKD. Respiratory status continued to decline and antibiotics broadened but continued to worsen.
chest pain/ right underneath her breast bone; This spontaneous case was reported by a pharmacist and describes the occurrence of CHEST PAIN (chest pain/ right underneath her breast bone) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHEST PAIN (chest pain/ right underneath her breast bone). On 22-Mar-2021, CHEST PAIN (chest pain/ right underneath her breast bone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment information was provided.
Started with fever of 99.4 which rose to 101.4 at about 2:30 am. I ended up taking tylenol at about 2:30 am and my fever broke by time I woke up at 6:30 am
On 6/17/15, pt presented at clinic with rash on left deltoid, 1 cm below bandaid impression area.
Everything ached; No arthritis pain until Wednesday (after shot on tuesday)/Sprained ankle in January - hasn't hurt in weeks, it ached; Ended up sleeping a lot and couldn't get warm but never ran a fever; Had a bit of a sore arm at injection site, but not as severe as the first shot; This is a spontaneous report from a contactable consumer (patient). A 54-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP6955), via an unspecified route of administration, administered in right arm on 23Mar2021 13:00 (at the age of 54-years-old) as dose 2, single for covid-19 immunization at  Workplace clinic. The medical history included sprained ankle in January, hasn't hurt in weeks, it ached and breast cancer from Sep2018 to an unknown date. Concomitant medication(s) included atorvastatin (LIPITOR [ATORVASTATIN]), celecoxib (CELEBREX), tamoxifen (TAMOXIFEN) and Multivitamin. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in right arm on 01Mar2021 10:45 (at the age of 54-years-old) as dose 1, single for covid-19 immunisation and experienced sore arm at injection site. Patient had allergies to medications, food, or other products: sulfa drugs and levequin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported everything ached. Did a lot of hand needle work over the weekend, no arthritis pain until Wednesday (after shot on Tuesday) on 24Mar2021. Sprained ankle in January, hasn't hurt in weeks, it ached. Ended up sleeping a lot and couldn't get warm but never ran a fever. Woke up at 1 am and many of the aches were gone. Also had a bit of a sore arm at injection site, but not as severe as the first shot. The patient reported I began feeling unwell the afternoon at 12:00 of 24Mar2021, (approximately 24 hours after 2nd dose). At 3 pm I went to take a nap and was in bed until the next morning. I reported first thing in the morning on 25Mar2021, and I was feeling much better by then. The outcome was recovering for the events.   No follow-up attempts are needed. No further information is expected.
Vaccinator verbally confirmed with the patient that she was due for a second dose of Pfizer and patient said "yes;" the patient received Pfizer.  Patient did not have her vaccination card from her first dose with her.  When charting the second dose, the vaccinator noted that she was charted in system as having received Moderna for her first dose.  Patient was informed of this situation by the vaccinator.  Patient was observed for twenty minutes, no adverse reaction noted, patient left the vaccine clinic in no distress.
pt recv vax 1DEC95 & later day,devel;a severe itchy feeling all over body,w//no physical sx;sx inc in severity & the itchy feeling peeked approx 8 days p/vax;tx w/DPH & pred;
red, slightly warm upper left deltoid arm, 4x4, 48 hours post injection